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Abstract: A monovalent antivenom was produced by immunizing two horses with venom of the pit viper 
Bothrops asper (Ophidia: VipeIidae). Although development of the immune response against four tolde 
and enzymatic activities of the venom was similar in both horses during the fmt two thirds of the immu­
nization schedule, antibody response in one of the horses reached much higher levels in the last part oC the 
immunization. Immunoelectrophoretic analysis indicates that there were precipitating antibodies in the 
sera of these horses during all the stages of immunization. However, immunoprecipitation did not correlate 
with the ability of sera to neutralize toxic activities of B. asper venom. Monovalent antivenom was more 
effective than the commercially available polyvalent antivenom in the neutralization of Bothrops asper 
venom. On the other hand, despite the fact that it neutralizes lethal and hemorrhagic activities of the venoms 
of Lachesia muta and Crotalus durissus durissus, it was less effective than polyvalent antivenom in these 
neutralizations. Moreover, it does not neutralize defibrinating activity induced by these two venoms, whereas 
it neutralizes this effect in the case of B. asper venom. It is proposed that monovalent antivenom may be 
highly effective in the case of envenomations induced by Bothrops asper venom; its use in treating accidents 
by L. muta and C. durissus would be indicated only if polyvalent antivenom is not available. Results also 
demonstrate that it is important to monitor antibody response individually in horses being irnmunized 
fOl antivenom production, due to the conspicuous variability in the response of different animals. 
Bothrops asper is responsible for the large 
majority of snakebite cases in Central America 
(Bolaños 1982). Current1y, the polyvalent 
antivenom produced at the Instituto Clodo­
miro Picado in Costa Rica is being used in 
several Central American countries to treat 
accidents induced by crotaline snakes. 1his 
antivenom is produced in horses by immuniza­
tion with a mixture of equal parts of the 
venoms of Bothrops asper, Lachesis muta and 
Crotalus durissus durissus (Bolaños and Cerdas 
1980). Previous studies have demonstrated that 
polyvalent antivenom is high1y effective in the 
neutralization of toxic and enzymatic activities 
of Central American crotaline venoms (Gutié­
rrez et al. 1981, 1985, 1987a. Gené et al. 
1985, Rojas et al. 1987). The only effect 
which is poorly neutralized is the edema-
511 
forrning activity (Lomonte 1985; Gutiérrez 
et al. 1986). 
In the past years there has been a significant 
,increment in the production of polyvalent 
antivenom in Costa Rica. If this trend 
continues, there is a potential problem with 
venom supply, since although the reserves of 
B. asper venom are high, those of L. muta 
and e durissus venoms have decreased recent1y 
due to the difficulty in collecting these snakes 
in the field. 1his fact, together with the 
observation that the majority of accidents are 
inflicted by B. asper, prompted us to produce a 
monovalent anti-B. asper antivenom in order 
to study its neutralizing capacity against 
homologous and heterologous crotaline 
venoms. 
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On the other hand, there is a need of more 
studies dealing with the development of 
immune response in horses l!sed to produce 
antivenoms. In this work we followed the 
humoral immune response against toxic and 
enzymatic activities of B. asper venom in 
horses utilized to produce this monovalent 
antivenom. 
MATERIAL AND METHODS 
Venams: The venoms of the snakes Bathrops 
asper, Lachesis muta stenaphrys and Crotalus 
durissus durissus were obtained from specimens 
collected in different regions of Costa Rica and 
maintained at the Instituto Clodomiro Picado. 
Once obtained, venoms were frozen, lyophilized 
and kept at -200C. 
Immunizatian schedule and plasma iractiana­
tian: Two adult horses, which had not been 
previously injected with snake venoms, were 
immunized with venom obtained from adult 
Bathrops asper specimens collected in the 
Atlantic region of Costa Rica and kept at the 
Instituto Clodomiro Picado. The immunization 
schedule is shown in Table 1. At different 
times along immunization, blood samples 
were obtained from the jugular vein imme­
diately before venom injection: sera were 
separated, distributed in aliquots and 
maintained at -200C until used. At the end 
of immunization, horses were bled and plasma 
fractionated by ammonium sulfate precipita­
tion. In sorne experiments, the polyvalent 
antivenom produced in Costa Rica (Bolaños 
and Cerdas 1980) was used for comparative 
purposes. 
Neutralizatian ai lethality: It was determined 
by incubating different proportions of venom 
and antivenom for 30 minutes at 370 C. 
Then 0.5 mI of the mixtures (containing 
4 LD50 of venom) were injected intrape­
ritoneally in groups of four mice (16-18 g 
body weight). Deaths were recorded during 
48 hours and data were analyzed according 
to the Spearman-Karber method (W.H.O. 
1981). Neutralization was expressed as effective 
dose 50% (ED50), defined as the antivenom/ 
venom ratio which protects 50% of the po­
pulation. 
Neutralizatian ai hemarrhage and protealysís: 
The were determined by experiments with 
preincubation of venom and antivenom, as 
described by Gutiérrez et al (1985). Neutra­
lization was expressed as effective dose 50% 
(ED50), defmed as the antivenom/venom 
ratio that reduces in a 50% the activity of 
venom·alone. 
Neatralizatian al indirect hema/ysís: The 
technique described by Gutiérrez et al. (1988) 
was used. Venom and antivenom were mixed 
in different proportions and incubated for 30 
minutes at 370C. Then, samples of the mixtures 
were added to wells made on a gel containig 
0.8% agarose with erythrocytes, egg yolk 
and CaC12. Plates were incubated at 370C 
for 20 hours after which the diameter of 
hemolytic at 370C for 20 hours after which 
the diameter of hemolytic halos were measured. 
Neutralization was expressed as effective dose 
50%, defined as the antivenom/venom ratio 
that reduces in a 50% the diameter of the halo 
induced by venom alone. 
Neutralizatían ai edema: The technique of 
Yamakawa et al. (1976) modified by Gutié­
rrez et al. (1986) was used. Groups of four 
mice (20-22 g) were injected with various 
volumes of antivenom (100 pI, 200 pI and 
400 ti!) intravenously. Five minutes later, 
animals were injected subcutaneously in the 
right foot pad with a dose of venom equivalent 
to 6 mínimum edema-forming doses dissolved 
in 50 pI of phosphate-buffered saline solution, 
pH 7.2. The left foot pad was injected with 
50 pI of saline solution in the same conditions. 
Edema was evaluated 6 hours after injection 
as described elsewhere (Gutiérrez et al 1986). 
Neutralization ai defibrinatíng activity: The 
procedure of Theakston and Reid (1978), 
modified by Gutiérrez et al. (1987), was 
followed. Several mixtures of venom and 
antivenom were incubated at 370C for 30 
minutes. Then, 0.2 mI (containing two 
minimum defibrinating doses of venom) were 
injected intravenously in the tail vein of groups 
of four mi ce (10-22 g). After one hour, mice 
were anesthetized with ether and bled by 
cardiac puncture. After incubation during 
one hour at room temperature, the formation 
of dots was observed. Neutralization was 
expressed as effective dose, defined as the 
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lowest antivenom/venom ratio wbich neutra­
lized defibrinating activity in all mice tested. 
Immunoelectrophoresis: Venoms were separat­
ed by electrophoresis on 1 % agarose gels in 
0.025 M barbital buffer, pH 8.2 (Ouchterlony 
and Nilsson 1978). After electrophoresis, 
two channels were made in the gel and filled 
with either polyvalent or monovalent 
ativenom. After 24 hours of diffusion at room 
temperature in a humid chamber, gels were 
washed several times with saline solution and 
stained with Amidoblack 10B. The number of 
precipitin arcs was recorded. For comparison, 
samples of polyvalent antivenom were tested 
simultaneously with each sample of monovalent 
antisera. 
RESULTS 
Development o[ immune response: Antibody 
production against B. asper venom components 
reached higher levels in horse No. 1 than in 
horse No. 2, although during the first two 
tbirds of the immunization schedule both 
horses had a relatively similar response (Fig. 1). 
In agreement with previous publications (Gené 
et al. 1985, Gutiérrez et al. 1985) neutraliza­
tion of hemorrhage and proteolysis was more 
effective than neutralization of lethality and 
indirect hemolysis. The development of 
antibody response against lethal, hemorrhagic, 
and indirect hemolytic effects showed a similar 
time-course. However, response against 
proteolytic activity presented a different 
pattern, since the striking difference observed 
between the two ho!ses regarding neutralization 
of lethality, hemorrhage and hemolysis was 
not as pronounced in the case of of proteolysis 
(Fig. 1). 
Analysis of immunoelectrophoretic results 
indicates the presence of precipitating anti­
bodies against several venom components 
even at the earliest times of immunization 
(Fig. 2, Table 3). For instance, after the tbird 
injection (corresponding to 0.083 mg venom), 
sera from horses 1 and 2 forrned seven and 
eight precipitin bands, respectively, when 
confronted against B. asper venom. At the 
end of the immunization, monovalent antisera 
formed 11  precipitin arcs when confronted 
with B. asper venom. In the same conditions, 
the commercially avaílable polyvalent 
antivenom forrned 11  bands against the same 
venom (Fig. 2). 
Neutralizing capacity o[ antivenom: The final 
monovalent antivenom was tested for its ability 
to neutralize lethal, hemorrhagic, defibrinat­
ing and edema-forrning activities of the venom 
of Bothrops asper, Lachesis muta stenophrys 
and Crotalus durissu& durissus. Table 3 and 
fig. 2 show that monovalent antivenom was 
bighIy effective in neutralizing toxic activities 
of B. asper venom, with the exception of 
edema-forrning effect which was onIy partially 
neutralized. On the other hand, monovalent 
antivenom was partially effective in neutralizing 
the venoms of L. muta and C. durissus, being 
more effective against the first one (Table 3, 
Fig. 3). Interestingly, monovalent antivenom 
neutralized the lethal effect of the three 
venoms tested. When compared with the 
polyvalent antivenom produced in Costa Rica 
at the Instituto Clodomiro Picado, the 
monovalent antivenom was more effective in 
the neutralization of B. asper venom, having 
a lower neutralizing ability against the venoms 
of L. muta and C. durissus (Table 3). 
When confronted with L. muta and C. 
durissus venoms by immunoelectrophoresis, 
monovalent antivenom formed many precipitin 
arcs, corroborating the high degree of cross­
reactivity between these venoms and that of 
B. aspero Nevertheless, there were bands result­
ant from the reaction between venoms and 
polyvalent antivenom that were absent when 
final monovalent antivenom was tested against 
heterologous venoms (Fig. 4). 
DISCUSSION 
Despite the fact that many centers in the 
world produce antivenoms (Chippaux and 
Goyffon 1983), there are very few studies 
related to the development of immune response 
in animals injected with snake venoms Of 
toxins. In tbis work, antibody production 
against components responsible of four toxic 
and enzymatic activities of B. asper venom 
was monitored. Results indicate that there 
was a remarkably different response in the 
two horses studied, since although neutralizing 
ability was similar during the first stages of the 
immunization schedule, horse No. 1 developed 
a much higher antibody response at later stages. 
Interestingly, this difference was not associated 
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Fig. l. Time-course of the development of antibody response in two horses immunized with Bothrops asper 
venom against four toxic and enzymatic activities of the venom. Neutralizing ability is expressed as (l/ED50) 
x 10', where ED50 is defined as the antivenom/venom ratio which neutralizes venom activity in a 500/0 o. 
The immunization schedule is shown in Table 1. (A) Development of antibody response against hemorrhagic 
activity; (B) Development of antibody response against indirect hemolytic activity; (e) Development of anti­
body response against lethal activity; (D) Development of antibody response against proteolytic activity. 
(e--e) horse No. 1, (0 -- 0) horse No. 2. 
with a different clinical response of both horses 
to venom injections. Since individual horses 
respond so differentIy to the immunization, 
it is important to monitor antibody response 
in each animal during immunization. This 
would help in the selection of horses with 
a good antibody titer, in order to bleed them 
and obtain a pool of plasma with high 
neutralizing ability. Such individual monitoring 
could be performed by in vitro techniques 
such as the one described by Gutiérrez et al. 
(1988) who showed that, in the case of the 
polyvalent antivenom produced in Costa Rica, 
neutralization of indirect hemolysis in vitro 
correlates significantly with neutralization of 
lethality. Since this is a simple and inexpensive 
assay, antibody response in individual horses 
could be easily evaluated by studying the 
neutralization of indirect hemolysis, thereby 
avoiding the large scale use of mice. 
Antibody response (expressed as ED50) 
raised earlier and reached higher levels against 
hemorrhagic toxins and proteases than against 
phospholipases A2 and lethal toxins. This find­
ing parallels previous results in that polyvalent 
antivenom is more efective in the neutralization 
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TABLE 1 
Immunization schedule used in the production of 
Monovalent anti-Bothrops asper antivenom 
DayNo. Venom injected (mg) * 
1 
10 
20 
30 
40 
50 
60 
70 
80 
90 
100 
110 
120 
130 
140 
150 
160 
0.083 
0.083 
0.083 
0.12 
0.23 
0.35 
0.50 
0.70 
1.0 
1.5 
3.0 
5.0 
10.0 
15.0 
30.0 
30.0 
50.0 
Adjuvant 
Incomplete Freund 
Sodium alginate 
Sodium alginate 
Sodium alginate 
Sodium algínate 
Sodium alginate 
Sodium algínate 
Sodium alginate 
Sodium alginate 
Sodium alginate 
Sodium algínate 
Sodium alginate 
Sodium alginate 
Sodium alginate 
Complete Freund 
Sodium alginate 
Sodium alginate 
* Injections were made subcutaneously. 
of proteolysis and hemorrhage thlln in the neu­
tralizlltion of indirect hemolysis and lethality 
(Bolaños and Cerdas 1980, Gutiérrez et al. 
1981, 1985, 1987a, Gené et al. 1985). Thus 
hemorrhagic and proteolytic components are 
more immunogenic, due perhaps to their high 
molecular weight which contrast with the re1a­
tively low molecular weight of phospholipases 
A2 (Tu 1977). 
Immunoelectrophoresis was more sensitive 
than neutralization assays in detecting antibody 
response since even at the earliest venom 
inoculations there were several precipitin bands 
when venom was confronted with antisera. 
However, immunoprecipitation was not use fuI 
in predicting the neutralizing ability of antisera 
as the number of precipitin bands was similar 
in sera from both horses at a11 times tested, 
in contrast to neutralizing ability which was 
higher in horse No. 1. 
Monovalent anti-B. asper antivenom has a 
higher neutralizing capacity when tested 
against B. asper venom than polyvalent anti­
venom (Table 3). Moreover, it cross reacts 
significantly with the venoms of L. muta 
and C. durissus, as revealed by irnmuno­
electrophoresis and neutralization assays. This 
type of neutralization against heterologous 
venoms has been also observed with other 
monovalent anti-Bothrops antivenoms (Siles et 
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Fig. 2. Immunoelectrophoresis of sera obtained from 
horses immunized with B. asper venom at different 
stages in the immunization.For comparative purposes, 
eommercíal polyvalent antivenom was al so eonfronted 
wíth B. asper venom. (A) Serum from horse No. 1 
eolleeted at day 20 of immunizatíon; (B) Serum from 
horse No. 1 eolleeted at day 60 of inmunization; and 
(C) Serum from horse N01 eolleeted at day 90 of 
immunization. Commercial polyvalent antivenom was 
placed in ehannels (P) whereas samples of monovalent 
antisera were plaeed in ehannels (M). Notiee the 
presenee of many precipitin ares even at a very early 
stage in the immunization proeess. 
TABLE 2 
Immunoelectrophoretic analysis of the antibody response 
in horses immunized with Bothrops asper venom 
Dose of venom injeeted 
(mg) 10 days before 
0.083 
0.12 
0.23 
0.35 
1.0 
1.5 
3.0 
10.0 
30.0 
50.0 
Number of precípitin ares 
in immunoeleetrophoresis* 
Horse No. 1 
7 
8 
7 
8 
8 
7 
8 
12 
12 
11 
Horse No. 2 
8 
7 
7 
8 
8 
8 
9 
11 
11 
11 
* For comparison, eommereially-available polyvalent 
antivenom formed 11 precipitin ares when eonfronted 
wíth B. asper venom in identical experimental eondi­
tions. 
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Fig. 3. Neutralization of edema-forming activity of 
three snake venoms by monovalent anti B. asper 
antivenom. In order to express neutralization of edema 
on percentage basis, swelling induced by venoms alone 
was considered as 100% edema. (. - .) Neutrali­
zation of C. durissus venom; (o -- --- o) Neutraliza­
tion of L. muta venom; (6, -- 6,) Neutralization of 
B. asper venom. In the cases of L. muta and B. asper, 
antivenom reduced edema-forming activity significan­
tJy ( P  < 0.05) at all doses tested. 
TABLE 3 
Comparison o[ rhe ability afmar/ovalent ond polyvolent antivenoms ro neutralize 
lethality, hemorrhage and difibrination induced by Ihe venoms o[ 
Bothrops aspero Lachesis muta and Crotalus durissus durissus. 
Venom Toxic activity 
Bothrops asper Lethality 
Hemorrhage 
Defibrination 
Lachesis muta Lethality 
Hemorrhage 
Defibrination 
Crota/us durissus Lethality 
dun'ssus Hemorrhage 
Defibrination 
Neu tralizing ability 
(ED50 ) * 
Monovalent Polyvalent 
antivenom antivenom 
216 333** 
70 135*** 
400 600**** 
333 400** 
250 85*** 
>4000 600**** 
1390 666** 
840 150*** 
>4000 400**"'* 
Expressed as effective dose 50% (ratio of ¡JI antivenom/mg venom in 
which the effect is neutralized 50%). 
According to Bolaños and Cerdas (1980), 
According to Glltiérrez et al. (1985). 
Gené, J.A. (llnpublished data). 
al. 1978/79). However, despite the fact that 
monovalent anti-B asper antivenom was 
effective in neutralizing lethality and hemo­
rrhage of L. muta and e d durissus venoms, 
it was ineffective against defibrinating activity 
(Table 3). Regarding edema, monovalent and 
polyvalent antivenoms have a similar neutraliz­
ing ability (Gutiérrez et al. 1986). Surprisingly, 
neither antivenom was capable to reduce edema 
1) 
A + 
jJ 
B + 
p 
e + 
Fig. 4. Immunoelectrophoresis of polyvalent and 
monovalent antivenoms against the venoms of 
Bothrops asper (A), Crotalus durissus durissus (B) and 
Lachesis muta stenophrys (C). Channels labelled as (P) 
correspond to polyvalent antivenom and those labelled 
as (M) correspond to monovalent antivenom. 
induced by e d durissus at any of the doses 
tested (Lomonte 1985, Rojas et al. 1987). 
In conclusion, it is proposed that although 
monovalent anti B. asper antivenom ís highly 
effective in the neutralization of B. asper 
venom, its use in treating accidents by L. 
muta and e d durissus seems to be indicated 
onIy if polyvalent antivenom is not available. 
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RESUMEN 
En el Instituto Clodomiro Picado se produ­
jo un suero monovalente contra el veneno de 
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la serpiente Bothrops asper (terciopelo). Du­
rante las primeras etapas del proceso los caba­
llos inmunizados mostraron un título similar 
en lo que respecta a la neutralización del vene­
no; sin embargo, uno de ellos mostró un título 
muy superior en la última fase de la inmuniza­
ción. El suero monovalente fue más efectivo 
que el suero polivalente comercial para neutra­
lizar el veneno de B. aspero Por otra parte, el 
suero monovalente fue menos efectivo que el 
polivalente para neutralizar las actividades le­
tal y hemorrágica de los venenos de Lachesis 
muta (cascabel muda) y Crotalus durissus 
(cascabel). Más aún, el monovalente no neu­
tralizó la actividad desfibrinante de estos dos 
venenos. Se propone que el suero monovalen­
te anti-B asper es altamente efectivo en la 
neutralización del veneno homólogo, en tanto 
que su empleo en el tratamiento de envenena­
mientos por L. muta y e durissus se justifica 
sólo cuando el suero polivalente no esté dispo­
nible. 
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